8 Ways CROs Support Regulatory Compliance

Contract Research Organizations (CROs) play a significant role in supporting regulatory compliance in clinical investigations. Here are several ways CROs support regulatory compliance:

1. Expertise in Regulatory Requirements: CROs have in-depth knowledge of regulatory guidelines and requirements issued by regulatory authorities such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in the European Union. They stay up-to-date with the latest regulations, ensuring that clinical investigations adhere to all applicable guidelines.

2. Protocol Development: CROs assist in the development of study protocols that comply with regulatory requirements. They ensure that the protocols are scientifically sound, ethically conducted, and align with regulatory expectations. CROs also help investigators navigate the complex regulatory landscape, considering factors such as patient safety, data integrity, and ethical considerations.

3. Regulatory Submissions: CROs support investigators in preparing and submitting regulatory documents, such as Investigational New Drug (IND) applications in the U.S. or Clinical Trial Applications (CTAs) in the EU. They ensure that these submissions are complete, accurate, and comply with the regulatory requirements, including the submission of essential study documentation.

4. Ethics Committee and Institutional Review Board (IRB) Coordination: CROs facilitate the ethical review process by working closely with ethics committees or IRBs. They help investigators prepare the necessary documentation, obtain ethics committee approvals, and address any queries or concerns raised during the review process. CROs ensure that the clinical investigation meets the ethical standards set by regulatory authorities.

5. Monitoring and Auditing: CROs conduct monitoring activities to ensure ongoing regulatory compliance during the clinical investigation. They regularly visit clinical sites to verify that the study is being conducted according to the protocol, applicable regulations, and good clinical practice (GCP) guidelines. Additionally, CROs may perform internal and external audits to identify any compliance gaps and recommend corrective actions.

6. Data Management and Quality Assurance: CROs assist in the collection, management, and analysis of clinical data, ensuring compliance with regulatory requirements for data integrity, confidentiality, and accuracy. They implement quality assurance measures, including data validation and source data verification, to maintain the highest standards of regulatory compliance.

7. Safety Reporting: CROs play a critical role in pharmacovigilance, ensuring the timely and accurate reporting of adverse events (AEs) and serious adverse events (SAEs) during the clinical investigation. They adhere to regulatory guidelines on safety reporting, collaborate with investigators to collect and assess safety data, and submit required safety reports to regulatory authorities as per the regulations.

8. Regulatory Inspections and Audits: CROs support investigators during regulatory inspections and audits. They help prepare for these inspections, respond to regulatory queries, and address any findings or observations raised by the regulatory authorities. CROs assist in maintaining audit readiness and ensure compliance with regulatory requirements throughout the investigation.

Overall, CROs act as partners to investigators, providing comprehensive support to ensure regulatory compliance in clinical investigations. They bring expertise, experience, and efficient processes to assist investigators in meeting regulatory requirements at every stage of the study.

ColoPlex Biomarker Data Published in Journal of Clinical Oncology

Abstract. Background: Colorectal cancer (CRC) is the third most common cancer worldwide motivating national screening strategies utilizing fecal immunochemical tests (FIT). Blood-based biomarkers could be an alternative method to increase compliance in population-based screening programs for early detection of CRC. We aimed to identify new blood-based biomarkers that could be potential candidates for use in colorectal cancer screening.



The development and commercialization of medical devices, including diagnostics, require a significant investment of time, resources, and expertise. To navigate the complex regulatory approval process and bring a device to market, many medical device companies partner with contract research organizations (CROs). In this article, we will explore the role of CROs in the diagnostics industry, the benefits of working with a CRO, and the different services that CROs provide to help companies bring their diagnostic devices to market.

AACC 2022

Want to chat with us during AACC? We want to see you in Chicago. Use the link below to schedule time with EDP during the show.   We'd love to schedule some time to meet you at AACC next week. In attendance will be Eric Mayer, CEO, Jon Dancy our Business Development...

Luminex Partner Spotlight

Luminex Partner Spotlight

Early detection makes a real difference in outcomes for cancer patients. But for cases of colorectal cancer, detecting tumors in the earliest stages has been virtually impossible. The team at EDP Biotech is committed to changing that by developing a simple, accurate, blood-based diagnostic test for biomarkers of colorectal cancer.

By Abby Kousouris Published: Aug. 17, 2021 at 7:25 PM EDT KNOXVILLE, Tenn. (WVLT) - A local Knoxville company says they’re seeing more demand for COVID-19 testing. EDP Biotech Corporation has different options available for people who want to find out if they have...

Contact us

Call Us

(255) 352-6258

Email Us


Our Location

5678 Extra Rd. #123
San Francisco, CA 96120

Get in touch